Results 171 to 180 of about 332,672 (384)

Creatine metabolism: energy homeostasis, immunity and cancer biology

Nature Reviews Endocrinology, 2020
L. Kazak, P. Cohen
semanticscholar   +1 more source

Impact of Diabetes on Long‐Term Outcomes of Percutaneous Coronary Intervention for Coronary Bifurcation Lesions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Diabetes mellitus (DM) is a well‐known risk factor for cardiovascular diseases, including coronary artery diseases (CAD). Complex percutaneous coronary intervention (PCI) such as PCI for bifurcation lesions often yields poor outcomes, especially in DM patients.
Subin Lim, Soon Jun Hong, Ju Hyeon Kim, Jung‐Joon Cha, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Do‐Sun Lim, Chang‐Wook Nam, the COBIS III investigators, Hyo‐Soo Kim, Woo Jung Chun, Seung‐Ho Hur, Seung Hwan Han, Seung‐Woon Rha, In‐Ho Chae, Jin‐Ok Jeong, Jung Ho Heo, Junghan Yoon, Ki Hong Choi, Young Bin Song, Hyeon‐Cheol Gwon, Jong‐Seon Park, Myeong‐Ki Hong, Joon‐Hyung Doh, Kwang Soo Cha, Doo‐Il Kim, Sang Yeub Lee, Kiyuk Chang, So‐Yeon Choi, Myung Ho Jeong, Bon‐Kwon Koo   +31 more
wiley   +1 more source

Corrigendum: A Pilot Study on the Cutoff Value of Related Brain Metabolite in Chinese Elderly Patients With Mild Cognitive Impairment Using MRS

Frontiers in Aging Neuroscience, 2021
Lihua Zhao, Jinlong Teng, Wei Mai, Jiahui Su, Bihan Yu, Xiucheng Nong, Chong Li, Yichen Wei, Gaoxiong Duan, Xiangming Deng, Demao Deng, Shangjie Chen   +11 more
doaj   +1 more source

The cataract and glucosuria associated monocarboxylate transporter MCT12 is a new creatine transporter [PDF]

, 2017
Creatine transport has been assigned to creatine transporter 1 (CRT1), encoded by mental retardation associated SLC6A8. Here, we identified a second creatine transporter (CRT2) known as monocarboxylate transporter 12 (MCT12), encoded by the cataract and ...
Abplanalp, Jeannette, Berger, Wolfgang, Braun, Philipp, Camargo, Simone M.R., Kloeckener-Gruissem, Barbara, Laczko, Endre, Munier, Francis L., Neidhardt, John, Philp, Nancy J., Schorderet, Daniel F., Verrey, François, Zuercher, Jurian   +11 more
core  

An Euroheart‐Based Percutaneous Coronary Intervention Registry in Vietnam: Design, Rationale, and Preliminary Results

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background As a cardiac interventional procedure, percutaneous coronary intervention (PCI) is increasingly becoming the most widely adopted across the globe. With increasing implementation in practice, the use of PCI registries to evaluate safety and effectiveness has grown internationally.
Vu Hoang Vu, Khang Duong Nguyen, Bao Thien Duong, Ngoc Minh Pham, Christopher M. Reid, Binh Quang Truong, Richard Norman   +6 more
wiley   +1 more source

NUTRITIONAL ERGOGENIC SUPPLEMENTS

Sakarya Üniversitesi Holistik Sağlık Dergisi, 2020
Nowadays, as competition in different sports branches increases, interest in ergogenic supports increases. Many athletes use nutritional supplements to reduce the percentage of body fat as well as to increase performance.
İbrahim Hakkı Çağıran
doaj  

Safety, Tolerability, and Pharmacokinetics of Donanemab in Healthy Chinese Participants: A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Study

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Alzheimer's disease (AD), characterized by β‐amyloid (Aβ) plaques and neurofibrillary tangles, is the leading cause of dementia globally. Donanemab is a humanized immunoglobulin G1 in development as a treatment to slow AD progression. This study aimed to evaluate the safety, tolerability, pharmacokinetics (PKs), and immunogenicity of donanemab
Junyu Xu, Nan Zhao, Yihui Wang, Ivelina Gueorguieva, Chenxi Qian, Yimin Cui   +5 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Exposure‐Response Relationships for Axatilimab in Patients with Chronic Graft‐Versus‐Host Disease

Clinical Pharmacology &Therapeutics, EarlyView.
Axatilimab, a high‐affinity humanized monoclonal antibody that targets colony‐stimulating factor 1 receptor, is approved for the treatment of chronic graft‐versus‐host disease (cGVHD). Here, we describe the exposure‐response relationships for efficacy and safety in patients with cGVHD who received axatilimab.
Yan‐ou Yang, Alina Volkova, Victor Sokolov, Xing Liu, Cristina Leon, Yuri Kosinsky, Jennifer Sheng, Xuejun Chen   +7 more
wiley   +1 more source

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

Clinical Pharmacology &Therapeutics, EarlyView.
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith, Michael P. Douglas, Christina L. Aquilante, Patricia A. Deverka, Beth Devine, Henry M. Dunnenberger, Philip E. Empey, Daniel L. Hertz, Andrew A. Monte, Ann M. Moyer, Jai N. Patel, Victoria M. Pratt, Loren Saulsberry, Stuart A. Scott, Deepak Voora, Erica L. Woodahl, Michelle Whirl‐Carrillo, Akinyemi Oni‐Orisan, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +18 more
wiley   +1 more source